Skip to main content
. 2012 Dec 26;7(12):e52672. doi: 10.1371/journal.pone.0052672

Table 2. Hypo-methylated and up-regulated concordant epigenes.

GeneID Description Symbol Δ5 mc (%) DS FC SM ALSoD& OS
58475 membrane-spanning 4-domains, subfamily A, member 7 MS4A7 6 −19.0 4.6
1439 colony stimulating factor 2 receptor, beta, low-affinity CSF2RB 6.6 −35.4 3.8
9056 solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 SLC7A7 6.6 −18.6 3.5
822 capping protein (actin filament), gelsolin-like CAPG 5.8 −13.9 3.4
6556 solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 SLC11A1 8.6 −34.4 3.1
54209 triggering receptor expressed on myeloid cells 2 TREM2 7.1 −26.0 2.9
912 CD1d molecule CD1D 5.6 −19.7 2.8
10457 glycoprotein (transmembrane) nmb GPNMB 10.1 −43.1 2.8
2203 fructose-1,6-bisphosphatase 1 FBP1 7.7 −96.5 2.7
11006 leukocyte immunoglobulin-like receptor, subfamily B, member 4 LILRB4 4.6 −14.0 2.7
27036 sialic acid binding Ig-like lectin 7 SIGLEC7 5.3 −15.9 2.7
4046 lymphocyte-specific protein 1 LSP1 6.4 −20.1 2.7
864 runt-related transcription factor 3 RUNX3 7.5 −32.8 2.6
11025 leukocyte immunoglobulin-like receptor, subfamily B, member 3 LILRB3 5.9 −14.0 2.5
2207 Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide FCER1G 5.5 −20.2 2.4
10261 immunoglobulin superfamily, member 6 IGSF6 10.2 −50.2 2.3
286256 lipocalin 12 LCN12 5.2 −18.4 2.3
1230 chemokine (C-C motif) receptor 1 CCR1 7.3 −25.2 2.3
51225 ABI family, member 3 ABI3 6.3 -19.2 2.3
1522 cathepsin Z CTSZ 5.8 −39.3 2.2
26157 GTPase, IMAP family member 2 GIMAP2 7.2 −35.0 2.2
10023 frequently rearranged in advanced T-cell lymphomas FRAT1 5.2 −46.0 2.2
1117 chitinase 3-like 2 CHI3L2 7.1 −22.6 2.1
64344 hypoxia inducible factor 3, alpha subunit HIF3A 5.8 −48.9 2.1
10320 IKAROS family zinc finger 1 (Ikaros) IKZF1 6.8 −22.2 2.1
1051 CCAAT/enhancer binding protein (C/EBP), beta C/EBPB 4.9 −54.7 2.1
1601 disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) DAB2 3.9 −13.7 2.0
84898 plexin domain containing 2 PLXDC2 3 −23.7 2.0
10990 leukocyte immunoglobulin-like receptor, subfamily B, member 5 LILRB5 7.5 −36.6 2.0
254295 phytanoyl-CoA dioxygenase domain containing 1 PHYHD1 3.1 −13.6 1.9
4488 msh homeobox 2 MSX2 5.4 −51.9 1.9
558 AXL receptor tyrosine kinase AXL 3.3 −14.5 1.8
5359 phospholipid scramblase 1 PLSCR1 7.3 −82.6 1.8
23526 histocompatibility (minor) HA-1 HMHA1 0 −33.5 1.8
50856 C-type lectin domain family 4, member A CLEC4A 9.5 −45.3 1.7
116843 chromosome 6 open reading frame 192 C6orf192 3.4 −16.5 1.7
55544 RNA binding motif protein 38 RBM38 4.9 −20.8 1.7
23209 megalencephalic leukoencephalopathy with subcortical cysts 1 MLC1 7.4 −29.0 1.7
23418 crumbs homolog 1 (Drosophila) CRB1 6.2 −15.2 1.7
1501 catenin (cadherin-associated protein), delta 2 CTNND2 2.9 −18.0 1.6
5045 furin (paired basic amino acid cleaving enzyme) FURIN 5.9 −19.7 1.6
1317 solute carrier family 31 (copper transporters), member 1 SLC31A1 5.3 −19.4 1.6
123920 CKLF-like MARVEL transmembrane domain containing 3 CMTM3 3.9 −16.6 1.6
6776 signal transducer and activator of transcription 5A STAT5A 4.2 −16.6 1.6
57522 SLIT-ROBO Rho GTPase activating protein 1 SRGAP1 0.3 −43.9 1.5
9404 leupaxin LPXN 4 −13.9 1.5
122618 phospholipase D family, member 4 PLD4 5.5 −18.0 1.5
64859 oligonucleotide/oligosaccharide-binding fold containing 2A OBFC2A 7.2 −99.8 1.5
10628 thioredoxin interacting protein TXNIP 4.3 −26.1 1.4
79939 solute carrier family 35, member E1 SLC35E1 0 −46.6 1.3
5660 prosaposin PSAP 0 −33.5 1.3

Genes are ordered by expression fold change (FC). Percent methylation change (Δ5 mc (%)) is calculated by |BetaALS – Betacontrol|/Betacontrol. DiffScore (DF), Differential methylation (a transformation of the p-value; p = 0.05, p = 0.01, p = 0.001 are equivalent to DiffScore = ±13, ±20, ±30, respectively). Fold change (FC) in gene expression ‘✓’ indicates that the corresponding gene was identified as an ALS-associated gene by SciMiner (SM), the ALSoD database, and other high-throughput microarray studies (OS) on human ALS spinal cord samples, respectively. See Table S2 more details.